European Union

How to build and maintain a requirements traceability matrix for medical devices — linking user needs, design inputs, outputs, risk controls, verification, and validation under FDA 21 CFR 820.30, ISO 13485:2016, IEC 62304, and EU MDR.

A complete guide to the European Commission's December 2025 proposal to simplify MDR and IVDR. Covers the new Rule 11 for software, indefinite certificate validity, regulatory sandboxes, breakthrough and orphan device pathways, fixed conformity timelines, SME fee reductions, and the expected legislative timeline through 2027.

A complete guide to Field Safety Corrective Actions under EU MDR — when an FSCA is required, reporting timelines (2/10/15 days), how to prepare a Field Safety Notice (FSN), competent authority notification, EUDAMED integration, and how FSCA differs from FDA recalls.

A complete guide to medical device complaint handling — regulatory requirements under FDA 21 CFR 820 (QMSR), ISO 13485, and EU MDR, step-by-step process, MDR reportability decisions, CAPA integration, and documentation best practices.

How to classify four common borderline products — hand sanitizer, mouthwash, personal lubricants, and data recorders — across FDA, EU MDR, Brazil ANVISA, and Mexico COFEPRIS. Includes decision trees, regulation citations, and jurisdiction-by-jurisdiction comparison tables.

The complete guide to drug-device combination product regulation — FDA jurisdiction (OCP, RFD, 21 CFR Part 4), EU MDR Article 117, Notified Body Opinions, QMSR changes, CGMP requirements, market pathways, and post-market obligations.

Role-by-role action playbook for the May 28, 2026 EUDAMED mandatory deadline — covering actor registration, UDI/device registration, certificate uploads, and market surveillance obligations with a countdown checklist and member-state penalty matrix.

A strategic map of 25+ countries where CE marking provides regulatory leverage — organized by mechanism: full reliance, abridged review, evidence-only acceptance, and reference-only. Know which markets your CE Mark unlocks and what extra steps remain.

Operational playbook for manufacturers that missed the May 26, 2024 Notified Body written agreement deadline under Regulation (EU) 2023/607 — covering legal status of non-qualifying devices, market withdrawal timelines, fresh MDR application routes, sell-off rules, and specific examples by device class.

A complete guide to the regulatory pathway for digital therapeutics — including FDA clearance strategies (510(k), De Novo, PMA), EU MDR classification, Germany's DiGA reimbursement program, approved DTx products, clinical evidence requirements, and what's changing in 2026.

Everything you need to know about validating medical device packaging to ISO 11607 — including sterile barrier systems, material qualification, accelerated aging, distribution simulation, seal strength testing (ASTM F88), bubble leak testing (ASTM F2096), dye penetration, shelf-life claims, FDA and EU MDR requirements, and step-by-step validation workflows.

Comprehensive guide to the EU AI Act requirements for AI-enabled medical devices — covering high-risk classification, conformity assessment, the dual compliance model with MDR/IVDR, data governance, transparency, human oversight, and the August 2026 enforcement deadline.

How Germany procures and reimburses medical devices through the GKV statutory health insurance system — G-DRG case-based payments, NUB innovative device pathway, Hilfsmittelverzeichnis medical aids, DiGA digital health applications, GPO group purchasing, hospital tendering, BfArM registration, and practical strategies for foreign manufacturers entering Europe's largest medical device market.

Transparent benchmark of medical device regulatory consulting fees across 16 countries and regions — covering hourly rates by consultant tier, factors that drive cost, and how to budget for registration projects in the US, EU, Japan, Korea, China, India, Brazil, Saudi Arabia, and more.

A data-driven breakdown of every cost component for CE marking under EU MDR — notified body fees, clinical evaluation, technical documentation, authorized representative, ISO 13485, and ongoing compliance costs with 2026-specific figures.

A comprehensive guide to EU Authorized Representative (EC REP) requirements under EU MDR and IVDR. Covers Article 11 obligations, mandate requirements, costs, PRRC obligations, EUDAMED registration, and how to select the right EU AR for your medical device or IVD company.

A complete guide to EU MDR and IVDR transition deadlines for legacy devices. Covers Article 120 MDR and Article 110 IVDR transitional provisions, class-specific deadlines, conditions for eligibility, EUDAMED requirements, and practical steps to maintain EU market access.

A comprehensive guide to the world's largest medical device companies ranked by revenue — including Medtronic, Johnson & Johnson, Abbott, Siemens Healthineers, and more — with 2026 market data, strategic shifts, and what's driving growth.

A practical walkthrough of all 7 IVDR classification rules in Annex VIII — with real device examples, software classification guidance, the IVDD-to-IVDR shift, and the 2025 EU simplification proposal that may reclassify certain IVDs.

Everything you need to know about EU MDR Notified Bodies and conformity assessment — how to select a Notified Body, assessment routes by device class (Annexes IX–XI), audit process, timeline, costs, and the 2025/2026 regulatory landscape.